US EditionPublished • loading... • Updated
Verapamil Shows Potential for Preserving Beta-Cell Function in Type 1 Diabetes
Summary by News Medical
3 Articles
3 Articles
News MedicalReposted by 
Industrial News
Industrial NewsVerapamil shows potential for preserving beta-cell function in type 1 diabetes
New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.
·United States
Read Full Article
Study reports potential effects of verapamil in slowing progression of type 1 diabetes
New research (the Ver-A-T1D trial) presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15–19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
